2005: SSY Group Limited - Summary | Jitta

SSY Group Limited

HKG:2005

Price
HK$2.80
Loss Chance
44.8%
5.38JITTA SCORE
42.39%Over Jitta Line
Jitta Ranking
52 / 241
477 / 2,581
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (27)
Recent Business Performance (29)
Financial Strength (82)
Return to Shareholders (53)
Competitive Advantage (46)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 58.33% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.38
42.39%
4.36
167.83%
3.80
223.30%
Pharmaceuticals
5.36
36.59%
6.81
167.94%
7.27
164.08%
COMPANY DESCRIPTION
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; research, development of biotechnology and related roducts; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. SSY Group Limited was founded in 1999 and is headquartered in Wan Chai, Hong Kong.